These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 6401892
1. An artificial circulation for the study of thrombolysis. The influence of flow rate and pressure on thrombolysis and a comparison between urokinase and tissue activator as thrombolytic agents. Walker JE, Flook V, Ogston D. Acta Haematol; 1983; 69(1):41-6. PubMed ID: 6401892 [Abstract] [Full Text] [Related]
2. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O, Rijken DC, Collen D. Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339 [Abstract] [Full Text] [Related]
3. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system. Mattsson C, Nyberg-Arrhenius V, Wallén P. Thromb Res; 1981 Mar 15; 21(6):535-45. PubMed ID: 7022741 [No Abstract] [Full Text] [Related]
4. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids. Thorsen S. Dan Med Bull; 1977 Oct 15; 24(5):189-206. PubMed ID: 908205 [No Abstract] [Full Text] [Related]
5. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators. Fry ET, Mack DL, Sobel BE. Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679 [Abstract] [Full Text] [Related]
6. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits. Hisano S, Sueishi K, Ishii Y, Tanaka K. Thromb Haemost; 1979 Jun 30; 41(4):796-803. PubMed ID: 483251 [Abstract] [Full Text] [Related]
7. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody. Bode C, Runge M, Eberle T, Freitag M, Kübler W, Haber E. Trans Assoc Am Physicians; 1989 Jun 30; 102():7-12. PubMed ID: 2517856 [No Abstract] [Full Text] [Related]
8. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK). Lipinski B, Gurewich V, Hyde E. Thromb Diath Haemorrh; 1975 Sep 30; 34(1):351. PubMed ID: 1188799 [No Abstract] [Full Text] [Related]
9. Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery. Gurll N, Zinner MJ, Turtinen L, Reynolds DG. Gastroenterology; 1978 Sep 30; 75(3):425-31. PubMed ID: 98390 [Abstract] [Full Text] [Related]
10. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids]. Páramo JA, Fernández FJ, Cuesta B, Paloma MJ, Rocha E. Sangre (Barc); 1989 Aug 30; 34(4):297-9. PubMed ID: 2505395 [No Abstract] [Full Text] [Related]
11. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator. Watahiki Y, Scully MF, Ellis V, Kakkar VV. Thromb Haemost; 1989 Jun 30; 61(3):502-6. PubMed ID: 2508259 [Abstract] [Full Text] [Related]
12. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D. Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163 [Abstract] [Full Text] [Related]
13. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator. Thorsen S, Astrup T. Haemostasis; 1976 Aug 03; 5(5):295-305. PubMed ID: 14058 [Abstract] [Full Text] [Related]
14. Superficial accumulation of plasminogen during plasma clot lysis. Sakharov DV, Rijken DC. Circulation; 1995 Oct 01; 92(7):1883-90. PubMed ID: 7671373 [Abstract] [Full Text] [Related]
15. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC. Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946 [Abstract] [Full Text] [Related]
16. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis. Thorsen S, Astrup T. Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113 [No Abstract] [Full Text] [Related]
17. Vasodilation due to urokinase in the canine femoral circulation. Gurll NJ, Zinner MJ, Callahan W, Reynolds DG. J Pharmacol Exp Ther; 1977 Jun 31; 201(3):731-7. PubMed ID: 864605 [Abstract] [Full Text] [Related]
18. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin]. Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA. Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Jun 31; (3):51-4. PubMed ID: 6342687 [Abstract] [Full Text] [Related]
19. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect. Gurewich V, Pannell R. Thromb Haemost; 1987 Jun 03; 57(3):372-3. PubMed ID: 3116707 [No Abstract] [Full Text] [Related]
20. Thrombolysis with prourokinase versus urokinase: an in vitro comparison. Fox D, Ouriel K, Green RM, Stoughton J, Riggs P, Cimino C. J Vasc Surg; 1996 Apr 03; 23(4):657-66. PubMed ID: 8627903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]